Silo Pharma, Inc. (SILO)

$2.63

-0.10 (-3.66%)
Rating:
Recommendation:
-
Symbol SILO
Price $2.63
Beta -0.757
Volume Avg. 0.46M
Market Cap 8.255M
Shares () -
52 Week Range 0.17-12.45
1y Target Est -
DCF Unlevered SILO DCF ->
DCF Levered SILO LDCF ->
ROE -35.76% Strong Sell
ROA -25.55% Sell
Operating Margin -
Debt / Equity 10.09% Neutral
P/E 0.80 Buy
P/B 0.44 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest SILO news


Healthcare
Biotechnology
Other OTC

Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. It is developing solutions to address various underserved conditions. The company seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders. The company focuses on merging traditional therapeutics with psychedelic research for people suffering from indications, such as depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.